Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
07/2000
07/12/2000EP0823429B1 Radicicol derivatives
07/06/2000WO2000039314A1 ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA
07/06/2000WO2000039113A1 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
07/06/2000WO2000038674A1 COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR
07/06/2000CA2356622A1 Compounds which affect mrna stability and uses therefor
07/06/2000CA2356621A1 Assay for identifying compounds which affect stability of mrna
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
06/2000
06/29/2000WO2000010965A3 Quaternary ammonium salts and their use as anti-hiv agents
06/27/2000US6080555 Incubating a genetically engineered polyketide synthase modified by deactivation of catalytic domain of ketosynthase of first module with diketide substrate and optionally recovering the produced polyketide; for generating libraries
06/07/2000EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use
06/02/2000WO2000031247A2 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/02/2000CA2350189A1 Recombinant methods and materials for producing epothilone and epothilone derivatives
05/2000
05/31/2000CN1255129A Tricyclic compounds
05/31/2000CN1254508A Process for preparing natural bud inhibitor and its application in inhibiting axillary bud of tobacco
05/24/2000CN1052722C Dibenzooxapine or thiapine derivative, its preparing method and drug composition
05/23/2000US6066499 Apparatus for preparation of mutants and preferential screening of appropriate gene expression in cells
05/18/2000WO2000027802A1 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
05/18/2000WO2000027627A1 Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
05/18/2000WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/18/2000CA2345459A1 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
05/17/2000EP1000928A1 Disease or insect pest control agent containing alkoxyimino-substituted bicyclic derivative as active ingredient
05/17/2000EP1000053A1 Macrocyclic lactones, compositions, and methods of use
05/16/2000US6063731 Brassinosteroid analogs useful as plant growth regulators
05/16/2000CA2126752C Benzopyran and related ltb4 antagonists
05/10/2000EP0883591B1 Process for preparing 1,6 hexane diol and caprolacton
05/09/2000US6060506 Benzopyran derivatives as melatonergic agents
05/04/2000WO2000024907A2 Library of novel "unnatural" natural products
05/04/2000CA2347128A1 Library of novel "unnatural" natural products
04/2000
04/27/2000WO2000023417A1 New compounds, their preparation and use
04/27/2000WO2000023416A1 New compounds, their preparation and use
04/27/2000WO2000023415A1 New compounds, their preparation and use
04/25/2000US6054474 Activating opioid receptors
04/06/2000WO1999067192A3 PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDE, KETONE, OXIME, AMINE, HYDROXAMIC ACID AND α,β-UNSATURATED CARBOXYLIC ACID AND ALDEHYDE COMPOUNDS
03/2000
03/29/2000CN1248974A Epothilones with a modified side chain
03/22/2000EP0987268A1 Epothilone A-N-oxide, epothilone B-N-oxide, process for their preparation and agent containing same
03/16/2000WO2000014033A1 The addition of oxygen nucleophiles to vinyl epoxides
03/16/2000WO1999067252A3 Epothilone derivatives and their synthesis and use
03/14/2000US6037477 Oxidation process of ethers
03/08/2000CN1246862A Epothilone analogs
03/08/2000CN1050127C Benocycloheptenes and benzoxepines preparing process thereof and pharmaceutical compositions containing them
03/02/2000WO2000010965A2 Quaternary ammonium salts and their use as anti-hiv agents
03/02/2000CA2337307A1 Quaternary ammonium salts and their use
03/01/2000EP0782573B1 Brefeldin a and analogs to improved synaptic transmission
02/2000
02/29/2000CA2117349C Benzopyrans and related ltb4 antagonists
02/16/2000EP0979821A1 Tricyclic compounds
02/16/2000EP0979286A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold
02/10/2000WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
02/10/2000DE19830060A1 New epothilone derivatives, used as mitosis regulators e.g. for treating malignant tumors, psoriasis or arthritis
02/09/2000EP0977563A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
02/03/2000WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
02/03/2000CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
02/02/2000EP0975638A1 Epothilones with a modified side chain
02/02/2000EP0975622A1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
02/01/2000US6020500 Hydroxy-substituted monolactones useful as intermediates for preparing lubricating oil and fuel additives
01/2000
01/27/2000WO2000003976A1 Imidamide derivatives
01/27/2000WO2000003705A1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid for the manufacture of a medicament for treating non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization
01/27/2000WO1999061599A3 Recombinant narbonolide polyketide synthase
01/27/2000CA2337773A1 Imidamide derivatives
01/26/2000EP0835251B1 Process for the production of lipoic acid
01/26/2000EP0643051B1 Process for Producing Alfa, Beta-Unsaturated Ketones
01/20/2000DE19924273A1 New nitro- or cyano-imideamide derivatives, used as insecticides, acaricides, ectoparasiticides or especially nematocides
01/19/2000EP0972771A1 Epsilon-caprolactone, process for producing the same, polycaprolactone obtained therefrom, and process for producing the polycaprolactone
01/13/2000WO2000001381A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
01/13/2000CA2345919A1 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
01/12/2000EP0969830A1 Drugs for memory enhancement
01/11/2000USRE36493 Fragrant macrocyclic lactones
01/11/2000US6013809 Analgesics
01/06/2000WO2000000489A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
01/06/2000WO2000000485A1 Epothilon derivatives, their preparation process, intermediate products and their pharmaceutical use
01/06/2000CA2336089A1 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands
01/05/2000CN1240418A Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
12/1999
12/29/1999WO1999067252A2 Epothilone derivatives and their synthesis and use
12/29/1999WO1999067192A2 PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDE, KETONE, OXIME, AMINE, HYDROXAMIC ACID AND α,β-UNSATURATED CARBOXYLIC ACID AND ALDEHYDE COMPOUNDS
12/29/1999CN1239886A Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agent
12/29/1999CA2335511A1 Process for the synthesis of .alpha.,.beta. alkenoate resin compounds
12/28/1999US6008380 Dihydroxylating (22e,24s)-24-ethyl-5-cholestan-2,22-diene-6 -one in chlorinated solvent and tetradecyletrimethyl permanganate to form intermediate, acylating the intermediate, oxidizing the intermediate formed
12/28/1999US6008185 Macrocyclic lactones as musk fragrance enhancers
12/07/1999US5998451 Lipoxygenase inhibitors
12/07/1999CA2200598C Novel anti-oxidative, tricyclic, condensed heterocyclic compound
12/02/1999WO1999061599A2 Recombinant narbonolide polyketide synthase
12/02/1999CA2328427A1 Recombinant narbonolide polyketide synthase
11/1999
11/30/1999US5994565 Process for producing purified ε-caprolactone
11/23/1999US5990104 Inhibiting nmda receptor activation by administering derivatives of given formula, such as 5,6,7,8,9,11,12-heptahydro-3-hydroxy-5-methyl-10-thia-5,11 -methanobenzocyclodecen-13-amine (sulphazocine)
11/17/1999CN1046507C Heterocyclic compounds for treatment of CNS and cardiovasular disorders
11/10/1999EP0955376A1 Antibiotic tkr 459, production method, and microorganism
11/09/1999US5981769 From adipic acid, 6-hydroxycaproic acid and small amounts of 1,4-cyclohexanediols by esterifying and hydrogenating a substream to give hexanediol and cyclizing 6-hydroxycaproic esters to give caprolactone
11/09/1999US5981571 Benzodioxa alkylene ethers as melatonergic agents
11/04/1999WO1999055690A1 Guanidine derivatives
11/04/1999WO1999055689A1 Radicicol derivatives
11/04/1999CA2325736A1 Guanidine derivatives
11/02/1999US5977165 Radicicol derivatives
10/1999
10/28/1999WO1999054319A1 12,13-modified epothilone derivatives
10/28/1999WO1999054318A1 12,13-cyclopropane epothilone derivatives
10/28/1999DE19808261A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols
10/28/1999CA2323609A1 12,13-cyclopropane epothilone derivatives
10/27/1999EP0952142A1 Compounds with protected hydroxy groups
10/26/1999US5972994 Microbial transformation products with antifungal properties
10/20/1999CN1232450A 2- and 2,5-substd. phenylketoenols
10/13/1999EP0949254A1 Process for producing cyclic ethers by liquid phase reaction
10/06/1999EP0946478A1 Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 36